A Case Series of Pulmonary Mucormycosis Caused by Rhizopus Microsporus

Case Report

Austin J Microbiol. 2021; 6(2): 1033.

A Case Series of Pulmonary Mucormycosis Caused by Rhizopus Microsporus

Mei Y2#, Sun P3#, Wang Z4 and Huang X1*

1Department of Clinical Laboratory, Children’s Hospital of Nanjing Medical University, Nanjing, China

2Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

3Department of Clinical Laboratory, Northern jiangsu people’s hospital, Yangzhou, China

4Liver Cancer Center, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China

#Both Authors Contributed Equally to this Work

*Corresponding author: Xu Huang, Department of Clinical Laboratory, The Affiliated Children’s Hospital of Nanjing Medical University, Nanjing, China

Received: July 28, 2021; Accepted: August 20, 2021; Published: August 27, 2021

Abstract

Mucormycosis is a relatively uncommon but intractable fungal infectious disease. The mortality is very high when it occurs. In this study, we reported a continuous cases of pulmonary mucormycosis in three patients who suffered from chronic kidney disease, history of renal transplantation and multiple myeloma in April 2017, respectively. Cultures were obtained from several specimens (pathological tissue, bronchoalveolar lavage fluid and sputum) and all identified as Rhizopus microsporus by Matrix-Assisted Laser Desorption Ionization Time- Of-Flight (MALDI-TOF) mass spectrometry and ITS DNA sequencing methods. In addition, they all showed susceptibility to amphotericin B and posaconazole. Unfortunately, even through the three patients all treated with amphotericin B and posaconazole, one man still died eventually. Clinicians should keep an eye on patients who are at high risk of acquiring this fatal disease and make early intervention strategies to reduce terrible outcomes.

Keywords: Rhizopus microspores; Mucormycosis; Mass spectrometry; Microbiological

Abbreviations

MALDI-TOF: Matrix-Assisted Laser Desorption Ionization Time-Of-Flight; MALDI-TOF MS: Matrix-Assisted Laser Desorption Ionization Time-Of-Flight Mass Spectrometry; MIC: Minimum Inhibitory Concentration; SOTs: Solid Organ Transplants; HSCTs: Hematopoietic Stem Cell Transplants; HM: Hematological Malignancies; CT: Computed Tomography; SDA: Sabouraud’s Agar

Background

Zygomycetes are classified into 2 orders, Mucorales and Entomophthorales [1]. Mucorales species cause mucormycosis, which is associated with high morbidity and mortality, particularly among immunosuppressed patients who are recipients of Solid Organ Transplants (SOTs) or of Hematopoietic Stem Cell Transplants (HSCTs) or who have Hematological Malignancies (HM). The oneyear cumulative TRANSNET study found that the incidence of mucormycosis was 10-fold lower than that of aspergillosis, occurring in 0.29% of HSCTs and 0.07% of SOTs [2,3]. The most frequently isolated fungi causing mucormycosis were from the genus Rhizopus (47%), in particular, Rhizopus microsporus followed by Rhizopus oryzae [4]. Mucormycosis was influenced by seasonal variations and usually occurred during the autumn months (August to November) [4,5]. We report a case series of disseminated mucormycosis with pulmonary infections occurred during the spring months (March to May) at the same university hospital in China.

Case Presentation

Case 1

A 52-year-old man was admitted to the hospital with clinical symptoms including a 4-year history of urine with foam and a history of pain and swelling in the lower limbs for 3 less than weeks. After a diagnosis of chronic kidney disease was made, the patient self- administered corticosteroids for a long time and underwent surgery for an arteriovenous fistula to prepare for multiple dialysis treatments. He underwent a CT-guided percutaneous lung biopsy three days after admission due to a continuous cough, the biopsy findings revealed nonseptate hyphae with acute and chronic inflammation (Figure 2A), and the tissue samples were positive on culture for Rhizopus microsporus, which was identified by Matrix-Assisted Laser Desorption Ionization Time-Of-Flight Mass Spectrometry (MALDITOF MS). Tragically, these results were obtained too late, and the patient did not receive antifungal treatment before he was discharged. In addition, a repeat chest Computed Tomography (CT) scan that was performed when he was discharged showed shrinkage of the lesion in the left upper lung lobe, while a chest CT scan performed at that time showed a lesion with cavitations in the left upper lung lobe and a lesion in the right upper lung lobe with a ground-glass appearance (Figure 1A). Finally, he discharged himself from the hospital with consent from the clinicians.